Technique may open doors to new treatments for many conditions, from cancer to autism
The genetic code stored in DNA determines everything from the color of our eyes to our susceptibility to disease. This has motivated scientists to sequence the human genome and develop ways to alter the genetic code, but many diseases are linked to a different fundamental molecule: RNA. As the intermediary genetic material that carries the genetic code from the cell’s nucleus, scientists have long sought an efficient method for targeting RNA in living cells.
Researchers at University of California, San Diego School of Medicine have now achieved this by applying the popular DNA-editing technique CRISPR-Cas9 to RNA.
The study is published March 17 in Cell.
“This work is the first example, to our knowledge, of targeting RNA in living cells with CRISPR-Cas9,” said senior author Gene Yeo, PhD, associate professor of cellular and molecular medicine. “Our current work focuses on tracking the movement of RNA inside the cell, but future developments could enable researchers to measure other RNA features or advance therapeutic approaches to correct disease-causing RNA behaviors.”
RNA’s location in a cell – and how and when it gets there – can influence whether proteins are produced in the right location and at the appropriate time. For instance, proteins important to neuronal connections in the brain, known as synapses, are produced from RNAs located at these contacts. Defective RNA transport is linked to a host of conditions ranging from autism to cancer and researchers need ways to measure RNA movement in order to develop treatments for these conditions.
Efforts to edit and measure DNA – as a means to alter protein production, study the underlying biology and correct defects to treat disease – got a big boost a few years ago. That’s when researchers discovered they could take CRISPR-Cas9, a naturally occurring defense mechanism bacteria use to fend off invading bacteria, and apply it to edit genes in mammalian systems.
Normally, CRISPR-Cas9 works like this: researchers design a “guide” RNA to match the sequence of a specific target gene. The RNA directs the Cas9 enzyme to the desired spot in the genome, where it cuts the DNA. The cell repairs the DNA break imprecisely, thus inactivating the gene, or researchers replace the section adjacent to the cut with a corrected version of the gene.
Until now, CRISPR-Cas9 could only be used to manipulate DNA. Yeo and colleagues at the University of California, Berkeley, have applied the technique to develop a flexible means of targeting RNA in live cells, also called RNA-targeted Cas9 (RCas9).
In order to target RNA instead of DNA, the researchers altered several features of the CRISPR-Cas9 system. Building upon previous work by co-author Jennifer Doudna, PhD, at UC Berkeley, they designed a short nucleic acid called the PAMmer that, along with the guide RNA, directs Cas9 to an RNA molecule.
To test the system, Yeo’s team targeted the RNA that encodes the proteins ACTB, TFRC and CCNA2. Then they watched as Cas9, fused with a fluorescent protein, revealed the movement of RNA into stress granules, a cluster of proteins and RNAs that form in a cell’s cytosol (the area outside the nucleus) when the cell is under stress. Stress granules are linked to neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS). This system allowed the team to track RNA over time, in live cells, without the need for artificial tags commonly used in other RNA-tracking techniques – an approach that can interfere with normal cellular processes.
“CRISPR-Cas9 is supporting a revolution in genomics and medicine based on its ability to target and modify human DNA,” said David Nelles, a UC San Diego Jacobs School of Engineering graduate student in Yeo’s lab and first author of the study. “DNA is the fundamental building block of life and we are just beginning to see the implications of genome engineering with CRISPR-Cas9, but many diseases including cancer and autism are linked to problems with another fundamental biological molecule – RNA.”
The Latest on: Disease-causing RNA behaviors
via Google News
The Latest on: Disease-causing RNA behaviors
- The Ehlers–Danlos syndromeson July 30, 2020 at 12:17 am
The Ehlers–Danlos syndromes (EDS) are a heterogeneous group of hereditary disorders of connective tissue, with common features including joint hypermobility, soft and hyperextensible skin ...
- Tsetse flies nurse their young, and understanding this unusual strategy could help fight the disease they spreadon July 28, 2020 at 5:01 pm
My colleagues and I hope that we can parlay our understanding of the molecular processes that regulate tsetses' milk production and mating behavior into new environmentally friendly, cost ...
- Technology Insight: Therapeutic RNA Interference - How Far from the Neurology Clinic?on July 18, 2020 at 5:00 pm
Although these defects might not lead to overt behavioral abnormalities in rodents ... explored as a powerful method of silencing disease-causing genes in incurable neurological disorders ...
- Genetic editing milestone in mouse model of Rett Syndromeon July 14, 2020 at 4:59 pm
RSRT funds six genetic approaches to restore a functioning MeCP2 protein in patients with disease causing mutations. Beyond RNA editing, other approaches are gene replacement, which is the closest ...
- Bioreactor Designs Respond to Evolving Needs in Vaccine Manufacturingon July 14, 2020 at 9:45 am
A vaccine usually contains parts of a disease-causing microorganism such as surface proteins or a weakened (attenuated) or killed microorganism. These biological agents stimulate the body’s adaptative ...
- Silencing of an ALS gene safely delivered to patients in new studyon July 8, 2020 at 5:00 pm
designed to silence a human disease-causing gene. Details of the treatment, which targeted the mutant SOD1 gene that causes ALS, appear in the New England Journal of Medicine. The study was led by ...
- Genome News and Researchon July 2, 2020 at 5:00 pm
A team of researchers from Children's Hospital of Philadelphia (CHOP) used a new method of pinpointing potential disease-causing changes in the genome to identify two new potential therapeutic ...
- Research finds new approach to treating certain neurological diseaseson July 1, 2020 at 8:04 am
Next, they successfully used a family of drugs known as ASOs (antisense oligonucleotides) to target the ribonucleic acid (RNA) strands ... to cut the disease-causing protein off at its source ...
- Huntington's Diseaseon May 28, 2020 at 12:24 pm
The most frequent psychiatric symptoms include irritability, depression, paranoia, and erratic behavior. Patients may also exhibit ... parent has a 50 percent chance of inheriting the disease-causing ...
- Top Genetics Stories of 2003on December 7, 2019 at 6:52 pm
The mistakes could waylay researchers looking for disease-causing mutations and affect court cases in ... regions that may increase susceptibility to depression and addictive behavior. A large ...
via Bing News